Ber has been reported as an autophagy inhibitor, with Fu et al. showing that Ber suppresses the accumulation of autophagosomes in breast cancer cells by upregulating BNIP3 and blocking autophagosome–lysosome fusion [38]. The gene discussed is BNIP3; the disease is breast carcinoma.